387 related articles for article (PubMed ID: 15155183)
1. Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
Dajcs JJ; Thibodeaux BA; Marquart ME; Girgis DO; Traidej M; O'Callaghan RJ
Antimicrob Agents Chemother; 2004 Jun; 48(6):1948-52. PubMed ID: 15155183
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
[TBL] [Abstract][Full Text] [Related]
3. Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis.
Thibodeaux BA; Dajcs JJ; Caballero AR; Marquart ME; Girgis DO; O'Callaghan RJ
Curr Eye Res; 2004 May; 28(5):337-42. PubMed ID: 15287370
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
Moreau JM; Green LC; Engel LS; Hill JM; O'Callaghan RJ
Curr Eye Res; 1998 Aug; 17(8):808-12. PubMed ID: 9723996
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of gemifloxacin for the treatment of experimental Staphylococcus aureus keratitis.
Wu X; Jiang H; Xu Y; Yue W; Yang L; Song Z; Chen H; Liu T
J Ocul Pharmacol Ther; 2012 Aug; 28(4):420-7. PubMed ID: 22360669
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Oguz H; Ozbilge H; Oguz E; Gurkan T
Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.
Balzli CL; McCormick CC; Caballero AR; Huang B; Wigington L; Smith E; Tang A; O'Callaghan RJ
J Cataract Refract Surg; 2008 Feb; 34(2):295-301. PubMed ID: 18242457
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of ciprofloxacin and ofloxacin in a prophylaxis model of Staphylococcus keratitis.
Dajcs JJ; Moreau JM; Thibodeaux BA; Traidej M; Austin MS; Marquart ME; Stroman DW; O'Callaghan RJ
Cornea; 2001 Nov; 20(8):878-80. PubMed ID: 11685070
[TBL] [Abstract][Full Text] [Related]
9. Penetration and effectiveness of prophylactic fluoroquinolones in experimental methicillin-sensitive or methicillin-resistant Staphylococcus aureus anterior chamber infections.
Balzli CL; Caballero AR; Tang A; Weeks AC; O'Callaghan RJ
J Cataract Refract Surg; 2010 Dec; 36(12):2160-7. PubMed ID: 21111321
[TBL] [Abstract][Full Text] [Related]
10. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
[TBL] [Abstract][Full Text] [Related]
11. Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis.
Callegan MC; Engel LS; Hill JM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1033-7. PubMed ID: 8125714
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis.
Sanders ME; Norcross EW; Moore QC; Shafiee A; Marquart ME
Cornea; 2009 Oct; 28(9):1055-60. PubMed ID: 19724203
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis.
Sanders ME; Moore QC; Norcross EW; Shafiee A; Marquart ME
J Ocul Pharmacol Ther; 2010 Apr; 26(2):193-8. PubMed ID: 20334537
[TBL] [Abstract][Full Text] [Related]
14. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
Marangon FB; Miller D; Muallem MS; Romano AC; Alfonso EC
Am J Ophthalmol; 2004 Mar; 137(3):453-8. PubMed ID: 15013867
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis.
Dajcs JJ; Moreau JM; Stroman DW; Schlech BA; Ke TL; Thibodeaux BA; Girgis DO; Caballero AR; O'Callaghan RJ
Curr Eye Res; 2001 Jul; 23(1):60-3. PubMed ID: 11821987
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits.
Aliprandis E; Ciralsky J; Lai H; Herling I; Katz HR
Cornea; 2005 Mar; 24(2):201-5. PubMed ID: 15725889
[TBL] [Abstract][Full Text] [Related]
17. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
Kowalski RP; Dhaliwal DK; Karenchak LM; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
Am J Ophthalmol; 2003 Sep; 136(3):500-5. PubMed ID: 12967804
[TBL] [Abstract][Full Text] [Related]
18. Benzalkonium chloride enhances antibacterial activity of gatifloxacin and reduces its propensity to select for fluoroquinolone-resistant strains.
Hesje CK; Borsos SD; Blondeau JM
J Ocul Pharmacol Ther; 2009 Aug; 25(4):329-34. PubMed ID: 19650708
[TBL] [Abstract][Full Text] [Related]
19. Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis.
Sanders ME; Moore QC; Norcross EW; Sanfilippo CM; Hesje CK; Shafiee A; Marquart ME
Cornea; 2011 Jan; 30(1):83-90. PubMed ID: 20847656
[TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit model.
Tungsiripat T; Sarayba MA; Kaufman MB; Sweet PM; Taban M; Carpenter TR; McDonnell PJ
Am J Ophthalmol; 2003 Jul; 136(1):76-81. PubMed ID: 12834673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
